Figure 2
Figure 2. Overall response rate by subgroup for patients treated with BR-ibrutinib. Number of responders (n)/total (N) in primary study (PCYC-1108).

Overall response rate by subgroup for patients treated with BR-ibrutinib. Number of responders (n)/total (N) in primary study (PCYC-1108).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal